ALB
Albemarle CorporationThesis. Albemarle sits 41.6% below its 52-week high on a bombed-out lithium tape, yet Q1 2026 delivered a sharp inflection: $319M net income and a +166.8% EPS surprise. At 9.9x forward earnings with a 0.79 PEG and 58% upside to consensus, the risk-reward skews long — but negative TTM ROE, insider selling, and lithium price volatility argue for accumulation into weakness rather than a full-conviction chase.
Scoreboard
At $129.02, ALB trades down 3.6% on the session and 41.6% off its $221.00 52-week high, sitting at just the 41st percentile of its 52-week range ($64.95-$221.00). The $15.2B market cap ($18.6B EV) prices in a still-depressed lithium cycle, yet the $204.46 mean analyst target implies 58.5% upside, with even the $83.28 low target near the cycle floor. Price sits below both the 50-day ($169.75) and 200-day ($149.47) averages — a stock repairing, not yet trending.
QoQ Changes
Q1 2026 revenue held flat sequentially at $1.429B (vs $1.428B in Q4 2025), but the earnings line inflected violently: basic EPS swung to +$2.35 from -$3.87 in Q4, with net income of $319M against a $414M prior-quarter loss. Reported actual EPS of $2.95 crushed the $1.11 consensus by +166.8%.
Gross profit rocketed to $501M (35.1% gross margin) in Q1 2026 from $198M (13.9%) in Q4 2025, as operating income flipped to $354M from $30M. This dwarfs the 18.5% TTM gross margin, signaling either lithium pricing/mix recovery or a one-time gain flattering the quarter.
TTM FCF margin of 13.0% and a 4.7% FCF yield are respectable for a capital-intensive miner mid-downcycle. Operating cash generation supports the balance sheet, but sustained capex for lithium expansion keeps free cash conversion cyclical.
Cash stands at $1.09B ($9.24/share) against $2.01B total debt, leaving a net debt position of $916M. Liquidity is comfortable — current ratio 2.07, quick ratio 1.11 — and debt/equity of ~19.8% is conservative for the sector.
Forward P/E of 9.94 and PEG of 0.79 screen cheap versus the stock's own history and specialty-chemical peers, while EV/EBITDA of 17.4x reflects trough EBITDA rather than structural richness. P/B of 2.0x against a $64.60 book value gives asset-based support.
The three-segment structure (Energy Storage, Specialties, Ketjen) is intact; no fresh M&A or restructuring is disclosed in the provided data. The only strategic signal is the Q2 2026 earnings release scheduled for August 5, 2026.
Ownership & Insider Activity
Institutional ownership is near-total at 96.25% (Capital World 8.3%, BlackRock 7.4%, Vanguard combined ~11.9%), while short interest is negligible at 0.07% of float (short ratio 0.03) — no bear thesis in positioning. SEC Form 4 data is the tell: CEO J. Kent Masters sold 16,393 shares across three open-market lots on 2026-05-15 at ~$183-185 (~$3.0M) and gifted 30,716 shares on 2026-03-12, driving net insider flow to -$5.02M with zero open-market buys. Insiders selling into the mid-$180s while the stock now trades at $129 is a caution flag, though largely comp-driven rather than a directional signal.
Recent Insider Transactions
| Date | Insider | Position | Shares | Value |
|---|---|---|---|---|
| 2026-05-15 | MASTERS JERRY KENT JR. | Chief Executive Officer | 16,393 | $3.0M |
| 2026-04-01 | WOLFF ALEJANDRO DANIEL | Director | 25 | $0.00 |
| 2026-03-12 | MASTERS JERRY KENT JR. | Chief Executive Officer | 30,716 | $5.0M |
| 2026-03-10 | MASTERS JERRY KENT JR. | Chief Executive Officer | 11,783 | $2.0M |
| 2026-03-02 | NORRIS ERIC S. | Officer | 4,490 | $0.00 |
| 2026-03-02 | MASTERS JERRY KENT JR. | Chief Executive Officer | 22,450 | $0.00 |
Earnings Quality
| Period | Actual EPS | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
| 2026-03-31 Q1 | $2.95 | $1.11 | +$1.84 | +166.82% |
| 2025-12-31 Q4 | $-0.53 | $-0.41 | $-0.12 | -28.48% |
| 2025-09-30 Q3 | $-0.19 | $-0.79 | +$0.60 | +75.86% |
| 2025-06-30 Q2 | $0.11 | $-0.83 | +$0.94 | +113.21% |
ALB beat consensus in 3 of the last 4 quarters (75% beat rate) with an outsized +81.9% average surprise, headlined by the +166.8% Q1 2026 blowout — evidence that sell-side estimates are badly miscalibrated to the downside on a volatile lithium print.
Surprises are widening and turning decisively positive (+113%, +76%, -28%, +167% across the trailing four quarters), indicating analysts are systematically underestimating the earnings recovery as lithium normalizes — a bullish setup into the August 5 report.
Analyst Action
| Month | Distribution | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|---|
| 2026-07 | 6 | 11 | 11 | 0 | 0 | |
| 2026-06 | 6 | 11 | 12 | 0 | 0 | |
| 2026-05 | 6 | 10 | 13 | 0 | 0 | |
| 2026-04 | 7 | 11 | 11 | 0 | 0 |
The rating mix has softened modestly at the margin: Strong Buy slipped from 7 (April) to 6 (July) and Hold sits at 11 after peaking at 13 in May, while Buy holds steady at 11 and Sell/Strong Sell remain at zero. Net composition is still constructive — 17 of 28 tracked ratings are Buy or better.
Momentum is mildly bearish over the window (analyst_bullish_drift -1, zero upgrades vs zero downgrades in 15 days), suggesting consensus is waiting for the Q2 print before re-rating.
Seven Essential Metrics
TTM EBITDA margin 19.4% and ROE -1.82% are dragged by prior-quarter losses, but Q1 2026's 24.8% operating margin and $319M net income show a live inflection.
Revenue growth of 32.7% and Q1 EPS of $2.95 vs a year-ago loss confirm the top- and bottom-line recovery is underway.
FCF margin of 13.0% and 4.7% FCF yield are solid, but conversion remains cyclical given heavy lithium capex.
Debt/equity ~19.8% and net debt of just $916M against $1.09B cash keep the balance sheet defensible through the cycle.
Beta of 1.35 and commodity-price dependence add volatility, but negligible short interest and strong liquidity (current ratio 2.07) cap tail risk.
Forward P/E 9.94, PEG 0.79 and P/S 2.77 sit at the low end of the range; only EV/EBITDA of 17.4x looks full, and that is on trough EBITDA.
No buyback signal in the data; share count of ~117.9M is stable with insider grants offset by open-market sales.
Albemarle historically pays a dividend, but no current yield is provided in the data; treat as capital-appreciation over income.
Competitive Snapshot
| Company | EBITDA Margin | 3Y Rev CAGR | FCF Margin | Leverage | Fwd P/E |
|---|---|---|---|---|---|
SQM Sociedad Quimica y Minera | ~30% | ~10% | ~10% | <1x | ~12x |
ALTM Arcadium Lithium | ~25% | ~25% | negative | ~1x | ~15x |
FMC FMC Corporation | ~20% | ~3% | ~10% | ~2x | ~11x |
PLL Piedmont Lithium | negative | n/a | negative | <1x | n/a |
Albemarle is the scale leader among Western lithium producers, with lower leverage (~19.8% D/E) and broader diversification (bromine, catalysts) than pure-plays like ALTM or PLL that lack downcycle cash cushions. Its 9.9x forward P/E is at a modest discount to SQM and roughly in line with FMC, but ALB offers the cleanest lithium-recovery leverage with an investment-grade balance sheet. Against loss-making juniors, ALB's Q1 profitability and $1.09B cash pile are a decisive quality advantage.
Business & Strategy
Three segments: Energy Storage (lithium carbonate/hydroxide/chloride for EV and grid batteries) is the growth and earnings swing factor; Specialties (bromine flame retardants, lithium fine chemicals, pharma intermediates) provides ballast; Ketjen supplies refining and performance catalysts. The mix skews Albemarle's fortunes to lithium pricing, with Specialties/Ketjen dampening the cycle.
Serves EV and battery manufacturers, grid-storage and solar customers, plus automotive, aerospace, pharmaceutical, electronics and conventional-energy end markets.
Predominantly volume x price on lithium and bromine compounds under long-term offtake and contract structures, supplemented by catalyst sales and technical/recycling services. Lithium contract mix (fixed vs spot-indexed) drives quarterly earnings variance.
Mining and conversion energy, brine/spodumene feedstock economics, and expansion capex are the primary cost levers, all sensitive to the lithium spot curve.
Albemarle's moat rests on tier-one brine and spodumene resource access (Chile, Australia), integrated conversion capacity, and entrenched OEM qualification — barriers juniors cannot quickly replicate. The 1887-founded franchise and IG balance sheet let it outlast peers through price troughs, but the moat is resource- and cost-curve-based, not pricing power over a commodity.
Monetary-Policy Sensitivity
- Lower discount rate lifts long-duration EV/battery demand valuations
- Cheaper capex funding for lithium expansion projects
- Weaker USD supports commodity and export pricing
As a capital-intensive, long-cycle commodity name, ALB is a beneficiary of falling rates through both a valuation re-rate and improved project economics. A dovish pivot would also stimulate the auto/EV financing channel that underpins lithium volume demand.
SWOT Analysis
- Scale leader in lithium with tier-one Chilean and Australian resources
- Conservative balance sheet — ~19.8% D/E, $1.09B cash, net debt only $916M
- Q1 2026 inflection: $319M net income, +166.8% EPS surprise
- Diversified by Specialties (bromine) and Ketjen catalysts to cushion the lithium cycle
- Negative TTM ROE (-1.82%) and profit margin (-4.2%) reflect lingering downcycle damage
- Earnings volatility — swung from -$3.87 to +$2.35 EPS in one quarter
- CEO net insider selling of $5.02M with zero open-market buys
- Q1 gross-margin spike (35%) may include non-recurring items
- Lithium price normalization drives operating leverage off a trough base
- 58% upside to $204.46 consensus target on modest re-rating
- Secular EV and grid-storage demand growth
- Cheap entry at 9.9x forward P/E and 0.79 PEG
- Renewed lithium oversupply and price weakness from Chinese/African capacity
- EV demand deceleration compressing battery-grade lithium offtake
- 1.35 beta amplifies drawdowns in risk-off tapes
- Chile/Australia regulatory and royalty risk on flagship assets
Catalysts & Event Risks
- 2026-08-05Q2 2026 earnings release
August 5 print will test whether the Q1 profitability inflection is durable; a repeat beat versus miscalibrated estimates is the primary near-term catalyst.
- Q3 2026Lithium spot-price trajectory
Continued spodumene/carbonate price recovery would drive consensus EPS upgrades and re-rate the stock off trough multiples.
- Q3 2026Potential analyst re-rating
A confirmatory Q2 could reverse the mild bearish drift and lift Strong Buy count back toward April levels.
- Q4 2026EV/grid-storage demand data
Battery-maker offtake volumes and OEM production schedules will validate or challenge the lithium demand recovery.
- Q4 2026Fed rate path
Rate cuts would re-rate long-duration commodity growth names and lower ALB's expansion funding costs.
The August 5 earnings release is the dominant near-term catalyst — with estimates repeatedly under-set (+81.9% avg surprise), the setup favors another upside print. Beyond that, the lithium spot curve is the real driver of the multi-quarter thesis.
Technical Analysis
ALB trades at $129.02, at the 41st percentile of its $64.95-$221.00 52-week range and 41.6% below the high, while holding a commanding 98.6% above the low. Price is below the 50-day ($169.75) and 200-day ($149.47) averages, so the tape is still repairing rather than trending — a base-building, accumulation profile. Support sits in the mid-$90s toward the cycle low, with the 50-day near $170 as first major resistance. Risk-reward favors staged entry: downside to structural support is ~26% versus 58% to consensus target, an asymmetric setup for patient capital.
Verdict
Macro context. The thesis hinges on the lithium price cycle: after a brutal 2024-25 oversupply washout, battery-grade lithium is the swing variable, with Q1 2026 hinting at normalization. Rate cuts and steady EV/grid-storage demand would reinforce a bottoming commodity backdrop favorable to the scale producer.
Albemarle offers asymmetric, best-in-class leverage to a lithium recovery: a scale leader trading at 9.9x forward earnings and 0.79 PEG, 41.6% off its high, with a Q1 2026 inflection ($319M net income, +166.8% EPS surprise) that estimates keep failing to capture. The offsets — negative TTM ROE, a violently volatile earnings line, and $5.02M of net CEO selling into the mid-$180s — argue against a full-conviction chase. ACCUMULATE into weakness toward the mid-$90s support with a $170 target (+31.8%); the August 5 print is the catalyst that converts this from cheap-and-cyclical to a re-rating.
Data source: Yahoo Finance / yfinance · fetched 7/8/2026, 7:14:54 AM